Arcus Biosciences's total assets for Q3 2024 were $1.25B, an increase of 5.56% from the previous quarter. RCUS total liabilities were $687.00M for the fiscal quarter, a 24.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.